TLDR: Bayer’s Consumer Health division has appointed Interpublic Group (IPG) as its exclusive global agency partner for all creative, media, and production efforts. This strategic consolidation, effective January 1, 2026, aims to leverage an integrated, tech-enabled marketing model, emphasizing data, generative AI, and creative innovation to enhance efficiency, personalization, and global consistency for its portfolio of self-care brands, including Aspirin, Bepanthen, Claritin, and Canesten.
Bayer’s Consumer Health division, a global leader in over-the-counter products, has announced a significant strategic shift in its marketing operations, appointing Interpublic Group (IPG) as its sole global agency partner. This move consolidates all creative, media, and production responsibilities under IPG, marking a departure from a multi-agency model that previously included WPP’s EssenceMediacom, IPG’s MullenLowe, Omnicom’s BBDO, and AnalogFolk. The new integrated agency structure is slated to go live on January 1, 2026, following a transition and handover period.
The decision underscores Bayer’s commitment to modernizing its marketing approach, aiming to strike a balance between global consistency and local relevance while enhancing efficiency and personalization at scale. The company’s portfolio of well-known self-care brands, such as Aspirin, Bepanthen, Claritin, and Canesten, will now benefit from a unified marketing strategy.
David Evendon-Challis, an executive in Bayer’s Consumer Health division, articulated the rationale behind the consolidation, stating, “Our new agency model addresses two competing forces in today’s marketing landscape – the need for more connection and individuality alongside greater efficiency and automation.” He further emphasized IPG’s understanding of the evolving digital landscape: “IPG understands how data, AI and creative must converge in this new era and came forward with a strong offering that brings together world-class capabilities, innovative technologies and creativity.”
Indeed, a key aspect of this partnership is the explicit intention to leverage generative AI tools and data-driven creative. Bayer aims to utilize these advanced technologies to deliver more localized and relevant campaigns, optimize global media buying power, and enhance content personalization. This focus on AI and data integration is expected to drive growth, deepen consumer trust, and yield measurable results across diverse markets.
Philippe Krakowsky, CEO of Interpublic Group, expressed enthusiasm for the partnership, highlighting the current demands of clients. “Clients today are looking for partners who can integrate creativity and media with data and technology in ways that are seamless and connected,” Krakowsky noted. He added that by bringing the full IPG ecosystem together, the agency will deliver “bold ideas, smarter media, and technology-enabled production that accelerate growth, deepen consumer trust, and drive results across markets.”
Also Read:
- Horizon Media and Havas Launch ‘Horizon Global’ Joint Venture, Creating a $20 Billion AI-Native Media Network
- Ad Age Spotlights AI’s Pivotal Role in 2025 Marketing Strategies
The announcement also comes amidst IPG’s planned combination with Omnicom, a deal expected to close by the end of the year. Both Evendon-Challis and Krakowsky alluded to the enhanced capabilities and additional talent that this larger entity could bring to Bayer’s account, further strengthening the partnership’s potential.
